Balanced news tone
News Sentiment
NATCOPHARM sentiment intelligence
NATCO Pharma Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
+5.7% over one week, +13.9% over four weeks, trend inactive, and near fair-value range.
Natco Pharma gains nearly 3% on ₹2,500 crore South Africa investment plan
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Natco Pharma gains nearly 3% on ₹2,500 crore South Africa investment plan
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Jul 2026 07:00
- Source
- Business Standard
Stocks in news: TCS, Nalco, Maruti Suzuki, Natco Pharma, HFCL
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 07:00
- Source
- The Economic Times
Natco Pharma Ltd outlines its strategy as a generic and specialty drug maker
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 07:00
- Source
- ad-hoc-news.de
Natco Pharma - Positive Breakout: These 11 stocks cross above their 200 DMAs
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- The Economic Times
39 NIFTY 500 stocks that delivered consistent growth over 5 years; Natco Pharma, ABB, M&M among top picks
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- Upstox
Natco Pharma Stock - Sunday background on operations and market position
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Jun 2026 07:00
- Source
- ad-hoc-news.de
Patent expiry: A $5 bn opportunity for Indian pharma majors, says report
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Jun 2026 07:00
- Source
- Business Standard
Stock Picks Today: Dixon Tech, Natco Pharma, Ather Energy, NMDC And More On Brokerages' Radar
- Tone
- Positive 58/100
- Event
- Market update
- Published
- 02 Jun 2026 07:00
- Source
- NDTV Profit
Earnings Beat: NATCO Pharma Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
- Tone
- Positive 82/100
- Event
- Earnings
- Published
- 01 Jun 2026 07:00
- Source
- simplywall.st
Natco Pharma stock price slips 20% in 2 days; should you buy, sell or hold?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jun 2026 07:00
- Source
- Business Standard
Natco Pharma shares crash 15% after weak Q4 results; net profit tanks 34% YoY
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 May 2026 07:00
- Source
- The Economic Times
Natco Pharma shares fall 12% as firm reports 34% drop in Q4 net profit at Rs 268 crore
- Tone
- Negative 38/100
- Event
- Earnings
- Published
- 29 May 2026 07:00
- Source
- Moneycontrol.com
Natco Pharma Q4 Results: Stock falls 8% as revenue drops 40%, margin shrinks
- Tone
- Negative 22/100
- Event
- Earnings
- Published
- 29 May 2026 07:00
- Source
- CNBC TV18
NATCO Pharma delivers 56% return after Fair Value identified undervaluation By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 May 2026 07:00
- Source
- Investing.com India
Natco Pharma: A high-margin business or a volatility trap at 10x earnings? | Smart Stocks News
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- The Indian Express
Market Trading Guide: Buy Ramco Systems, Natco Pharma and 2 more stocks on Wednesday for gains up to 14%
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 07 Apr 2026 07:00
- Source
- The Economic Times
Natco Pharma Share Price Gains 2.48% On Semaglutide Launch
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Mar 2026 07:00
- Source
- HDFC Sky
Natco Pharma shares rise 2.5% as firm launches Semaglutide generic injection multi-dose vials in India
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Mar 2026 07:00
- Source
- Moneycontrol.com
Weight is over! Pharma stocks jump up to 4% as patent for Ozempic's key ingredient expires; what lies ahea
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 Mar 2026 07:00
- Source
- The Economic Times
Natco rallies 5%, nears 52-week high; what's driving pharma stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Mar 2026 07:00
- Source
- Business Standard
Natco Pharma shares rise 3% in weak mkt on launching generic Pomalyst in US
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 04 Mar 2026 08:00
- Source
- Business Standard
NATCO Pharma (NSE:NATCOPHARM) Could Be A Buy For Its Upcoming Dividend
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 16 Feb 2026 08:00
- Source
- simplywall.st
Natco Pharma Share Price Jumps 11.78% to ₹920.90
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Feb 2026 08:00
- Source
- HDFC Sky
Natco Pharma shares surge over 10% on getting nod for diabetes drug Semaglutide in India
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 15 Feb 2026 08:00
- Source
- Upstox
NATCO Pharma (NSE:NATCOPHARM) Is Due To Pay A Dividend Of ₹1.50
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 15 Feb 2026 08:00
- Source
- simplywall.st
NATCO Pharma's (NSE:NATCOPHARM) three-year earnings growth trails the 18% YoY shareholder returns
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 04 Feb 2026 08:00
- Source
- simplywall.st
Insufficient Growth At NATCO Pharma Limited (NSE:NATCOPHARM) Hampers Share Price
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 13 Jan 2026 08:00
- Source
- simplywall.st
Natco Pharma Ltd. Share Price Today - Natco Pharma Ltd. Stock Price Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jan 2026 09:39
- Source
- CNBC TV18
Is NATCO Pharma (NSE:NATCOPHARM) A Risky Investment?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Dec 2025 08:00
- Source
- simplywall.st
Earnings Troubles May Signal Larger Issues for NATCO Pharma (NSE:NATCOPHARM) Shareholders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Nov 2025 08:00
- Source
- simplywall.st